GENETIC · Unmapped registry intervention
DNA and whole transcriptome mRNA sequencing
Find medicine records ·
Find other trials using this name
Clinical trial
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
NCT05111067
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedMolecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Triple Negative Breast Cancerunresolved
Interventions
Sponsors & collaborators
Nova Scotia Health Authoritylead sponsor
Obafemi Awolowo Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05111067 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.